Literature DB >> 27423996

Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery.

Akshaar Brahmbhatt1, Sanjay Misra2.   

Abstract

Peripheral arterial disease (PAD) affects over 8 million people in the United States alone. Although great strides have been made in reducing the burden of cardiovascular disease the prevalence of PAD is expected to rise with the age of global population. PAD characterized by narrowing of arterial blood can be asymptomatic or cause limb threatening claudication. It has been classically treated with bypass, but these techniques have been supplanted by endovascular therapy. Plain old balloon angioplasty has been successful in helping revascularize lesions, but its effect has not been durable because of restenosis. This prompted the creation of several technologies aimed at reducing restenosis. These advances slowly improved outcomes and the durability of endovascular management. Among the main tools used in current endovascular practice are drug-delivery devices aimed at inhibiting the inflammatory and proliferative pathways that lead to restenosis. This article examines the current drug-delivery technologies used in the superficial femoral artery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PAD; SFA; drug-coated balloon; drug-eluting stent

Mesh:

Substances:

Year:  2016        PMID: 27423996      PMCID: PMC4948300          DOI: 10.1053/j.tvir.2016.04.007

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  73 in total

Review 1.  In-stent stenosis: pathology and implications for the development of drug eluting stents.

Authors:  Martin R Bennett
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 2.  Drug-coated balloons for the prevention of vascular restenosis.

Authors:  William A Gray; Juan F Granada
Journal:  Circulation       Date:  2010-06-22       Impact factor: 29.690

Review 3.  In-stent restenosis in the superficial femoral artery.

Authors:  Louai Razzouk; Saurabh Aggarwal; Farzan Gorgani; Anvar Babaev
Journal:  Ann Vasc Surg       Date:  2013-03-25       Impact factor: 1.466

4.  Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.

Authors:  V Fuster; P Charlton; A Boyd
Journal:  Hum Gene Ther       Date:  2001-11-01       Impact factor: 5.695

Review 5.  Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

Authors:  Tullio Palmerini; Giuseppe Biondi-Zoccai; Diego Della Riva; Andrea Mariani; Manel Sabaté; Pieter C Smits; Christoph Kaiser; Fabrizio D'Ascenzo; Giacomo Frati; Massimo Mancone; Philippe Genereux; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-11-06       Impact factor: 24.094

6.  Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

Authors:  David R Holmes; Paul Teirstein; Lowell Satler; Michael Sketch; James O'Malley; Jeffery J Popma; Richard E Kuntz; Peter J Fitzgerald; Hong Wang; Eileen Caramanica; Sidney A Cohen
Journal:  JAMA       Date:  2006-03-12       Impact factor: 56.272

7.  Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.

Authors:  Sebastian Strieth; Martin E Eichhorn; Birgitta Sauer; Brita Schulze; Michael Teifel; Uwe Michaelis; Marc Dellian
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

8.  Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.

Authors:  Sreenivasulu Kilari; Indulekha Remadevi; Baofeng Zhao; Jing Pan; Robert Miao; Ramani Ramchandran; Paula E North; Ming You; Nader Rahimi; George A Wilkinson
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

9.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

10.  Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.

Authors:  Richard R Saxon; Arun Chervu; Paul A Jones; Tanvir K Bajwa; Dennis R Gable; Peter A Soukas; Richard J Begg; John G Adams; Gary M Ansel; Darren B Schneider; Charles M Eichler; Michael J Rush
Journal:  J Vasc Interv Radiol       Date:  2013-01-28       Impact factor: 3.464

View more
  1 in total

1.  Fate of Asymptomatic Limb after Kissing Stents in Aortoiliac Occlusive Disease.

Authors:  Faheem Asem Ahmad; Martin Michael Hennessy; Alexander Fredrik Nath
Journal:  Vasc Specialist Int       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.